Global medical rehabilitation services market is estimated to grow at a CAGR of 7.4% during the forecast period of 2023–2031 and is expected to reach a valuation of US$ 558.7 Mn by 2031 from 297.60 Mn in 2022.
The Asia Pacific stem cell therapy market is poised for substantial growth in the coming years, with a projected compound annual growth rate (CAGR) of 10.29% between 2023 and 2031. This growth is expected to drive the market value up to US$ 3,420.05 Mn by 2031, following a successful revenue performance of US$ 1,453.61 Mn in 2022.
Global exosome research market was valued at US$ 174.94 million in 2022 and is anticipated to record a revenue of US$ 1,158.04 Million by 2031 at a CAGR of 24.4% over the forecast period of 2023 to 2031.
India specialty drug distribution market generated a revenue of US$ 2,045.35 million in 2022 and is estimated to reach a valuation of US$ 5,997.7 million by 2031 at a CAGR of 12.93% during the forecast period 2023–2031.
ASEAN nutritional supplements market generated revenue of US$ 7,366.8 million in 2022 and it is estimated to reach valuation of US$ 14,847.3 million by 2031 at a CAGR of 8.4% during the forecast period, 2023–2031.
ASEAN & US corporate wellness market is anticipated to reach valuation of US$ 30.82 Bn in 2030 from US$ 18.29 Bn in 2021. The market is expected to register healthy growth at a CAGR of 5.88 % during the forecast period 2022–2030.
Japan pet cancer therapeutics market was valued at US$ 14.0 Million in 2021 and is projected to reach a valuation of US$ 26.1 Million by 2031 at a CAGR of 7.3% during the forecast period 2023-2031.
Global dermatology drugs market was valued at US$ 18.42 billion in 2022 and is estimated to reach a valuation of US$ 45.35 billion and 79.24 metric ton, in terms of volume by 2031. The market is anticipated to grow at a CAGR of 11.0% during the forecast period 2023-2031
Asia Pacific Dermal Fillers Treatment Market is estimated to witness a rise in revenue from US$ 810.3 Million in 2021 to US$ 1,650.3 Million by 2030. The market is registering a CAGR of 8.9% during the forecast period 2022-2030